Qianyi Wang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Serum immunoglobulin G levels in patients with cirrhosis due to autoimmune hepatitis or other etiologies.

Serum immunoglobulin G levels in patients with cirrhosis due to autoimmune hepatitis or other etiologies.

Journal: European journal of gastroenterology & hepatology

Published: August 19, 2025

MiR-122-5p modulates ferroptosis via SLC7A11: A potential therapeutic target in autoimmune hepatitis.

MiR-122-5p modulates ferroptosis via SLC7A11: A potential therapeutic target in autoimmune hepatitis.

Journal: Journal of translational autoimmunity

Published: June 11, 2025

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Journal: European journal of gastroenterology & hepatology

Published: May 09, 2025

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Journal: European journal of gastroenterology & hepatology

Published: May 09, 2025

An Unusual Cause of Secondary Sclerosing Cholangitis: A Case Report.

An Unusual Cause of Secondary Sclerosing Cholangitis: A Case Report.

Journal: Gastroenterology

Published: April 24, 2025

Efficacy and safety of electroacupuncture for metabolic dysfunction-associated fatty liver disease: a study protocol for a multicentre, randomised, sham acupuncture-controlled, patient-blinded clinical trial.

Efficacy and safety of electroacupuncture for metabolic dysfunction-associated fatty liver disease: a study protocol for a multicentre, randomised, sham acupuncture-controlled, patient-blinded clinical trial.

Journal: BMJ open

Published: November 14, 2024

Identification of abdominal MRI features associated with histopathological severity and treatment response in autoimmune hepatitis.

Identification of abdominal MRI features associated with histopathological severity and treatment response in autoimmune hepatitis.

Journal: European radiology

Published: June 03, 2024

Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis.

Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis.

Journal: Hepatology international

Published: May 08, 2024

Autoimmune hepatitis with confluent necrosis indicates severe liver injury but responds well to standard immunosuppressive therapy.

Autoimmune hepatitis with confluent necrosis indicates severe liver injury but responds well to standard immunosuppressive therapy.

Journal: Histology and histopathology

Published: December 21, 2023

The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange model.

The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange model.

Journal: Heliyon

Published: October 16, 2023

Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena.

Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena.

Journal: Therapeutic advances in gastroenterology

Published: August 16, 2023

Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD.

Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD.

Journal: Abdominal radiology (New York)

Published: August 15, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026